Background : Medicines are the most common medical interventions to relieve sufferings but as said rightly "drugs are double edged weapons'' with a potential to cause benefit, as well as harm.
INTRODUCTION
Medicines are the most common medical interventions to relieve sufferings but as said rightly "drugs are double edged weapons'' with a potential to cause benefit, as well as harm. 1 The most crucial step toward making drugs safer for human use is to prevent the occurrence of an adverse drug reaction (ADR). ADR is defined as "any response to a drug, which is noxious and unintended, and which occurs at doses normally used in man for prophylaxis, diagnosis or therapy of disease or for the modification of physiological function." 2 The incidence of ADRs varies from as low as 0.15% to as high as 30%. 3 They are a major clinical problem, accounting for 2-6% of all the hospital admissions.
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It is an inevitable consequence of drug therapy, as no pharmacotherapeutic agent is completely safe and more than 50% of approved drugs are associated with some type of adverse effec ts that are not detected prior to their approval for clinical use.
5,6 ADR reporting and monitoring activities are of vital importance for patient safety, which can generate valid data regarding causality association, preventability and severity of ADRs in the human population. This study was therefore designed to evaluate incidence and the patterns of ADRs from the reports collected from various clinical departments of this hospital and to establish the causal link between the suspected drug and the reaction by using the WHO causality definitions. uploaded in Vigiflow software and sent to National Coordinating Centre, Indian Pharmacopoeia Commission, Ghaziabad, which then tra nsmits the reports to the Uppsala Monitoring Center's ADR database where signal processing is carried out.
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MATERIAL AND METHODS
The 100 suspected ADR reports received by Pharmacovigilance unit at the Department of Pharmacology between January 2015 and june 2015 were evaluated and analyzed for the incidence and the patterns of ADRs on each ADR proforma. Data on demographic details for patient profile (age and sex), prescribed medications (generic name of the medicine, dose frequency, strength, date of start and stop) were evaluated. ADRs were evaluated with respect to description of the adverse event, onset and end of the adverse event, seriousness, information on de-challenge, rechallenge. Causality assessment was carried out using WHO-UMC global introspection method 9 and "Naranjo algorithm or ADR Probability Scale''respectively. 10 Seriousness of reaction was categorized as "serious" and "non-serious" according to WHO criteria. 
Data analysis
Data were entered in Microsoft Excel 2010. Descriptive analysis was done to assess mean ± SD and the percentages as applicable for age, gender, causa/tive drug, seriousness, severity, and causality.
RESULTS
A total of 100 ADR reports were reported. There was a predominance of females (58%) as compared to males (42%). Mean age of the patients was 40.3 years ± 16.4 years (standard deviation) with maximum number of patients in the age group of 30-60 years (35.33%).
The leading therapeutic class of medicines implicated were antimicrobials, including ß-lactam antibiotics (Ex: Penicillins), fluoroquinolones, macrolides, aminoglycosides, antifungals, antitubercular, antiprotozoals (51%), followed by NSAID's (20%).
The majority of reactions were non-serious (95%) and 5% serious. The causality was almost consistent with both Narinjo's and WHO probability scale. On causality assessment using WHO Probability Scale 77% ADRs were categorized as probable and 23% were categorized as possible. Naranjo's Probability Scale showed, 74% ADRs were categorized as probable (score ranging from 5 to 8) and 26% wer e categorized as possible (scores ranging from 1 to 4).
DISCUSSION
Since adverse drug reactions are one of the common causes for poor adherence to treatment, evaluation of ADRs may help clinicians to optimize 
9%
Others 10% The most commonly affected organ system was Skin (43%) followed by gastrointestinal (GIT) system (31%) . the drug regimens. In recent times, spontaneous reporting of ADRs has become the most favored method for practicing pharmacovigilance by the healthcare professionals. ADR reporting adds to increased vigilance and influence recommendations of drug use, which has now become a National Programme in the Indian context. The present study is an attempt to carry out an appraisal of spontaneous reported suspected ADRs in a tertiary care center and included 100 reports in 6 months period. The demographic details of the present analysis showed female gender predominance over males with respect to ADRs, which was similar to the findings of some other studies. 11, 12 Several other studies have found that ADRs are more common in males than in females. 13, 14 However, another study showed no differenc e in the occurrence of ADRs in male and female patients 15 showing thereby that the influence of gender may be incidental only and have no influence on the number of ADRs reported. The most frequently implicated group of medicines in the ADRs was antimicrobial agents, this finding is consistent with other studies. 16, 17 The organ system most often affected by ADRs in this evaluation was dermatological manifestations(43%). [18] [19] [20] The majority of reactions 95% wer e non-serious and 5% wer e serious. The causality was almost consistent with both Naranjo's probability scale and WHO global introspection method. Early identification and management of ADRs are essential to imply the safe and rational use of drugs as the impact on patient's quality of life is major. The current Indian scenario of Pharmacovigilance programme of India (PvPI) is upholding well and the combined effort of regulatory authorities and healthcare professionals is raising the data contribution but still there are many healthcare professionals totally unaware of the Pharmacovigilance programme and the need of reporting and monitoring of ADRs.
CONCLUSION
The monitoring and reporting of suspected ADRs by healthcare professionals aids in improved patient welfare. This also acts as an alerting mechanism for physicians. ADRs to drugs happen commonly, and their reporting is important for the early recognition and prevention of ADRs. It not only help in generating signals but also helps the regulatory authorities in making the policy decision. Furthermore, the awareness about risk factors and in-depth knowledge of the literature of ADRs can help physicians to identify patients with greater risk of ADRs. 
